Cell Source, Inc. (19)
Browse by Contract Category
Contracts
-
Form of Warrant issued to Purchasers of 8% Convertible Promissory Note
(Filed With SEC on November 13, 2020)
-
Sixth Amendment to Research and License Agreement effective December 31, 2019 between Yeda Research and Development Company Limited and Cell Source Limited
(Filed With SEC on March 30, 2020)
-
CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT
(Filed With SEC on August 14, 2019)
-
AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT
(Filed With SEC on May 20, 2019)
-
Form of 8% Convertible Promissory Note
(Filed With SEC on November 13, 2020)
-
Form of Consultant Stock Option Agreement
(Filed With SEC on November 13, 2020)
-
Form of Director Stock Option Agreement
(Filed With SEC on November 13, 2020)
-
Form of Warrant issued to Service Providers
(Filed With SEC on November 13, 2020)
-
Form of Warrant issued to Members of Scientific Advisory Board
(Filed With SEC on November 13, 2020)
-
Form of Securities Purchase Agreement between Cell Source, Inc. and the purchaser of 10% OID Convertible Promissory Note
(Filed With SEC on August 14, 2020)
-
Form of Warrant issued to purchaser of 10% OID Convertible Promissory Note
(Filed With SEC on August 14, 2020)
-
Form of 10% OID Convertible Promissory Note
(Filed With SEC on August 14, 2020)
-
Form of Placement Agent Warrant dated February 13, 2020
(Filed With SEC on May 15, 2020)
-
Convertible Promissory Note dated January 10, 2020
(Filed With SEC on May 15, 2020)
-
Convertible Note effective October 28, 2019
(Filed With SEC on March 30, 2020)
-
CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT
(Filed With SEC on August 14, 2019)
-
CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN
(Filed With SEC on August 14, 2019)
-
SPONSORED RESEARCH AGREEMENT
(Filed With SEC on April 1, 2019)
-
ยง 1 Subject matter
(Filed With SEC on April 1, 2019)